GSK3β inhibitor II

CAS No. 478482-75-6

GSK3β inhibitor II( —— )

Catalog No. M33773 CAS No. 478482-75-6

GSK3β inhibitor II is a GSK3β inhibitor. GSK3β inhibitor II exhibits the research potential of Alzheimer's disease (AD).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 29 In Stock
10MG 43 In Stock
25MG 91 In Stock
50MG 152 In Stock
100MG 207 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GSK3β inhibitor II
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK3β inhibitor II is a GSK3β inhibitor. GSK3β inhibitor II exhibits the research potential of Alzheimer's disease (AD).
  • Description
    GSK3β inhibitor II is an inhibitor ofGSK3β. GSK3β inhibitor II can be used for research of Alzheimer’s disease (AD).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    GSK-3
  • Recptor
    GSK-3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    478482-75-6
  • Formula Weight
    395.22
  • Molecular Formula
    C14H10IN3OS
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (126.51 mM; Ultrasonic (<60°C)
  • SMILES
    Ic1cccc(CSc2nnc(o2)-c2ccncc2)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Elangovan ND, et al. Screening of potential drug for Alzheimer's disease: a computational study with GSK-3 β inhibition through virtual screening, docking, and molecular dynamics simulation. J Biomol Struct Dyn. 2021 Nov;39(18):7065-7079. ?
molnova catalog
related products
  • GSK3-IN-2

    GSK3-IN-2 is a potent GSK3 inhibitor for the treatment of diabetes and neurodegenerative diseases.

  • BRD0705

    BRD0705 (BRD-0705) is a potent, paralog-selective GSK3α inhibitor with IC50 of 66 nM.

  • Methyliodobikinin

    Methyliodobikinin is a potent bikinin-like inhibitor targeting GSK3/Shaggy-like kinase, shows improved cell permeability.